Aurobindo Pharma, Glenmark Pharma hit 52-week highs

Aurobindo Pharma was up 9% at Rs 826, surging 22% in past three trading days after the company on Thursday announced the acquisition of Sandoz's generic business in the US for $900 million.

from Latest News https://ift.tt/2NSDGGl
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share